Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

PerkinElmer Inc.

BioPhotonics
May 2006
PerkinElmer Inc. of Wellesley, Mass., and George Mason University of Fairfax, Va., have announced a five-year research collaboration to develop approaches for cancer detection and risk stratification. Scientists plan to design clinical assay platforms that use amino acid identification of a protein fragment and its specific mass to identify biomarkers. The research will use the company’s BioXpression platform and the university’s discovery of an archive of protein fragments in human blood.

In other news, PerkinElmer has acquired Agilix Corp.’s protein labeling technology. The labels use isobaric mass tags to quantify expressed proteins from multiple samples. The company intends to use the technology to increase the reach of quantitative proteomics to drug discovery customers.

BiophotonicsBusinessRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.